InsidersTradesSigma
Follow the 上海凯宝 share price and the full directors' dealings record of the company, a listed equity based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 上海凯宝 has recorded 3 insider filings. Market capitalisation: €6.2bn. The latest transaction was reported on 22 June 2026 (Purchase). Among the most active insiders: 任立旺. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Shanghai Kaibao is a company specializing in the healthcare and pharmaceutical sector. It is listed on the XSHE market.